Table 1.
Cumulative proportion of esophageal adenocarcinoma by demographic and health-related characteristics of all study participants
| Characteristics | Number of people (n=411)a | Number of cases (n= 56) | Cumulative Proportion |
|---|---|---|---|
| Age (years) | |||
| 30–54 | 127 (30.9) | 11 (19.6) | 8.7% |
| 55–69 | 176 (42.8) | 23 (41.1) | 13.1% |
| ≥70 | 108 (26.3) | 22 (39.3) | 20.4% |
| Sex | |||
| Men | 334 (81.3) | 49 (87.5) | 14.7% |
| Women | 77 (18.7) | 7 (12.5) | 9.1% |
| Smoking Status | |||
| Never | 148 (36.0) | 14 (25.0) | 9.5% |
| Ever | 263 (64.0) | 42 (75.0) | 16.0% |
| Education | |||
| No college education | 135 (32.9) | 25 (44.6) | 18.5% |
| Any college education | 275 (67.1) | 31 (55.4) | 11.3% |
| Waist-to-hip ratioc | |||
| First quartile | 104 (25.4) | 11 (19.6) | 10.6% |
| Second quartile | 101 (24.7) | 15 (26.8) | 14.9% |
| Third quartile | 100 (24.5) | 14 (25.0) | 14.0% |
| Fourth quartile | 104 (25.4) | 16 (28.6) | 15.4% |
| NSAID use as of baseline | |||
| Never | 162 (39.5) | 26 (46.4) | 16.0% |
| Former | 79 (19.3) | 12 (21.4) | 15.2% |
| Current | 169 (41.2) | 18 (32.1) | 10.7% |
| High grade dysplasia at or before baseline | |||
| No | 328 (79.8) | 15 (26.8) | 4.6% |
| Yes | 83 (20.2) | 41 (73.2) | 49.4% |
| Statin use at baseline | |||
| No | 355 (86.4) | 50 (89.3) | 14.1% |
| Yes | 56 (13.6) | 6 (10.7) | 10.7% |
| Ever statin use over study | |||
| No | 265 (64.5) | 42 (75.0) | 15.8% |
| Yes | 146 (35.5) | 14 (25.0) | 9.6% |
a
1 value missing for education, baseline NSAIDs; 2 values missing waist-to-hip ratio
c
Quartiles determined within-sex: Quartile 1 upper value= 0.9306 (men), 0.8086 (women); Quartile 2 upper value= 0.9616 (men), 0.8651 (women); Quartile 3 upper value=0.9970 (men), 0.9110 (women); Quartile 4 upper value=1.142 (men), 1.035(women)